


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-10.95%
+2.43%
+1.62%
+34.90%
+2.13%
TEVA
Teva Pharma
$30.18
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive
TEVA Price Performance
$25.41 (+18.77%)
$18.45 (+63.58%)
$16.58 (+82.03%)
$22.62 (+33.42%)
TEVA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

TEVA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
TEVA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
TEVA Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayPFE
25.80
+0.08%
NVS
132.36
+0.90%
SNY
48.86
+1.24%
MRK
99.01
+1.42%
AZN
90.29
-1.33%
What is TEVA current stock price?
What are TEVA stock strengths?
What is TEVA Risk Level?
What is TEVA market cap and volume?
What is TEVA current Stock IQ?
Should I buy TEVA stock right now?
Is TEVA a Strong Buy right now?
What does a 'Strong Buy' rating mean for TEVA?
What does a 'Strong Sell' rating mean for TEVA?
What factors influence TEVA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-10.95%
+2.43%
+1.62%
+34.90%
+2.13%
TEVA
Teva Pharma
Current Price
$30.18
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive
Linked to TEVA
PFE
25.80
+0.08%
NVS
132.36
+0.90%
SNY
48.86
+1.24%
MRK
99.01
+1.42%
AZN
90.29
-1.33%

TEVA Price Performance
$25.41 (+18.77%)
$18.45 (+63.58%)
$16.58 (+82.03%)
$22.62 (+33.42%)
TEVA Analysts Opinion
TEVA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
TEVA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
TEVA Street Sentiment is extremely bullish and have positive views on the near-term outlook
TEVA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
TEVA Stock IQ
TEVA Latest Analysis
TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia. Teva files an NDA seeking FDA approval for its once-monthly olanzapine LAI for the treatment of adults with schizophrenia.
Wed Dec 10, 2025
Barclays Initiates Coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt (TEVA) with Overweight Recommendation. Fintel reports that on December 9 2025 Barclays initiated coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) with a Overweight recommendation. Analyst Price Forecast Suggests 99.76% Downside
Wed Dec 10, 2025
B of A Securities Maintains Teva Pharmaceutical Industries Limited - Depositary Receipt (TEVA) Buy Recommendation. Fintel reports that on December 9 2025 B of A Securities maintained coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) with a Buy recommendation. Analyst Price Forecast Suggests 99.76% Downside
Wed Dec 10, 2025
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play . Teva holds ish momentum trading above key SMAs as branded drugs and biosimilars drive growth despite generics softness.
Tue Dec 9, 2025
Goldman Sachs Maintains Teva Pharmaceutical Industries Limited - Depositary Receipt (TEVA) Buy Recommendation. Fintel reports that on December 8 2025 Goldman Sachs maintained coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) with a Buy recommendation. Analyst Price Forecast Suggests 99.77% Downside
Tue Dec 9, 2025
Unpacking the Latest Options Trading Trends in Teva Pharmaceutical Indus. Whales with a lot of money to spend have taken a noticeably ish stance on Looking at options history for Teva Pharmaceutical Indus (NYSE:TEVA) we detected 9 trades.If we consider the specifics of each trade it is accurate to state that 66% of the investors opened trades with ish expectations and 33% with bearish.From the overall spotted trades 3 are puts for a total amount of $145680 and 6 calls for a total amount of $3507
Mon Dec 8, 2025
3 Generic Drug Stocks to Watch Amid Changing United States Landscape. Generic drugmakers face United States pricing pressure but TEVA SDZNY and RDY gain momentum through complex generics and biosimilars.
Mon Dec 8, 2025
Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript.
Thu Dec 4, 2025
Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Tue Dec 2, 2025
Noteworthy ETF Inflows: IEFA SPOT SE TEVA. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF (Symbol: IEFA) where we have detected an approximate $176.8 million dollar inflow -- thats a 0.1% increase week over week
Tue Dec 2, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TEVA Stock trends
TEVA Stock performance
TEVA Stock analysis
TEVA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.